Works about FLUDARABINE
Results: 1099
Costs of toxicity during chemotherapy with CHOP, COP/CVP, and fludarabine.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 3, p. 166, doi. 10.1007/s10198-002-0112-y
- By:
- Publication type:
- Article
Kronik Lenfositik Losemili Hastalarda T Lenfosit Alt Gruplarının Değerlendirilmesi.
- Published in:
- Turkish Journal of Immunology, 2020, v. 8, n. 1, p. 6, doi. 10.25002/tji.2020.1240
- By:
- Publication type:
- Article
Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases.
- Published in:
- Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-025-01218-8
- By:
- Publication type:
- Article
Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00890-y
- By:
- Publication type:
- Article
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00763-w
- By:
- Publication type:
- Article
Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00675-9
- By:
- Publication type:
- Article
Design of an innovative aptasensor for the detection of chemotherapeutic drug Fludarabine phosphate.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-78039-5
- By:
- Publication type:
- Article
Chronic lymphocytic leukaemia cells drive the global CD4<sup>+</sup> T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4<sup>+</sup> forkhead box P3<sup>+</sup> T cells.
- Published in:
- Clinical & Experimental Immunology, 2011, v. 166, n. 2, p. 154, doi. 10.1111/j.1365-2249.2011.04466.x
- By:
- Publication type:
- Article
Non‐proteinuric renal al amyloidosis in waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1371, doi. 10.1038/bmt.2015.144
- By:
- Publication type:
- Article
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 7, p. 939, doi. 10.1038/bmt.2015.58
- By:
- Publication type:
- Article
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, p. S37, doi. 10.1038/bmt.2015.93
- By:
- Publication type:
- Article
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, p. S24, doi. 10.1038/bmt.2015.91
- By:
- Publication type:
- Article
Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 3, p. 367, doi. 10.1038/bmt.2014.269
- By:
- Publication type:
- Article
Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 248, doi. 10.1038/bmt.2014.250
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 9, p. 1162, doi. 10.1038/bmt.2014.131
- By:
- Publication type:
- Article
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 9, p. 1170, doi. 10.1038/bmt.2014.133
- By:
- Publication type:
- Article
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 913, doi. 10.1038/bmt.2014.84
- By:
- Publication type:
- Article
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 955, doi. 10.1038/bmt.2014.66
- By:
- Publication type:
- Article
Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 852, doi. 10.1038/bmt.2014.23
- By:
- Publication type:
- Article
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 485, doi. 10.1038/bmt.2013.214
- By:
- Publication type:
- Article
Stable long-term pulmonary function after fludarabine, antithymocyte globulin and i.v. BU for reduced-intensity conditioning allogeneic SCT.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 622, doi. 10.1038/bmt.2014.15
- By:
- Publication type:
- Article
Allogeneic transplantation after reduced-intensity conditioning with fludarabine-CY for both indolent and aggressive lymphoid malignancies.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 513, doi. 10.1038/bmt.2013.221
- By:
- Publication type:
- Article
Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 589, doi. 10.1038/bmt.2013.234
- By:
- Publication type:
- Article
Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 4, p. 519, doi. 10.1038/bmt.2013.224
- By:
- Publication type:
- Article
Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 248, doi. 10.1038/bmt.2013.167
- By:
- Publication type:
- Article
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 11, doi. 10.1038/bmt.2013.121
- By:
- Publication type:
- Article
Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 17, doi. 10.1038/bmt.2013.142
- By:
- Publication type:
- Article
Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 10, p. 1317, doi. 10.1038/bmt.2013.116
- By:
- Publication type:
- Article
Salvage allogeneic hematopoietic SCT for primary graft failure in children.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 9, p. 1173, doi. 10.1038/bmt.2013.36
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 9, p. 1179, doi. 10.1038/bmt.2013.37
- By:
- Publication type:
- Article
Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 8, p. 1098, doi. 10.1038/bmt.2013.3
- By:
- Publication type:
- Article
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 7, p. 982, doi. 10.1038/bmt.2012.261
- By:
- Publication type:
- Article
Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 7, p. 901, doi. 10.1038/bmt.2012.267
- By:
- Publication type:
- Article
Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 646, doi. 10.1038/bmt.2012.218
- By:
- Publication type:
- Article
Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 708, doi. 10.1038/bmt.2012.211
- By:
- Publication type:
- Article
Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 729, doi. 10.1038/bmt.2012.196
- By:
- Publication type:
- Article
Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 2, p. 196, doi. 10.1038/bmt.2012.251
- By:
- Publication type:
- Article
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 10, p. 1287, doi. 10.1038/bmt.2012.13
- By:
- Publication type:
- Article
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 10, p. 1274, doi. 10.1038/bmt.2012.4
- By:
- Publication type:
- Article
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 9, p. 1171, doi. 10.1038/bmt.2011.242
- By:
- Publication type:
- Article
Allo-SCT in a patient with CRMCC with aplastic anemia using a reduced intensity conditioning regimen.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1126, doi. 10.1038/bmt.2011.221
- By:
- Publication type:
- Article
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1112, doi. 10.1038/bmt.2011.231
- By:
- Publication type:
- Article
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 5, p. 700, doi. 10.1038/bmt.2011.158
- By:
- Publication type:
- Article
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 528, doi. 10.1038/bmt.2011.138
- By:
- Publication type:
- Article
Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 494, doi. 10.1038/bmt.2011.114
- By:
- Publication type:
- Article
Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 542, doi. 10.1038/bmt.2011.117
- By:
- Publication type:
- Article
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 488, doi. 10.1038/bmt.2011.109
- By:
- Publication type:
- Article
Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 3, p. 369, doi. 10.1038/bmt.2011.84
- By:
- Publication type:
- Article
Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 3, p. 374, doi. 10.1038/bmt.2011.86
- By:
- Publication type:
- Article